|
|
||||||||
From the Departments of Neurology (Drs. Vorgerd, Patzold, and Malin) and Pediatrics (Dr. Mortier), Ruhr-University, Bochum; and the Institute of Human Genetics (Drs. Bolz and Kubisch), University of Hamburg, Germany.
Address correspondence and reprint requests to Dr. Matthias Vorgerd, Department of Neurology, Kliniken Bergmannsheil, Ruhr-University Bochum, Bürkle-de-la-Camp-Platz 1, D-44789 Bochum, Germany; e-mail: matthias.vorgerd{at}ruhr-uni-bochum.de
OBJECTIVE: To characterize the phenotype of hereditary rippling muscle disease (RMD) and to report the results of genetic linkage studies.
BACKGROUND: RMD is a rare autosomal-dominant inherited muscle disorder. Individuals complain of muscle stiffness, exercise-induced muscle pain, and cramp-like sensations. The characteristic feature of RMD is increased mechanical muscle irritability, which is electrically silent in electromyographic examinations.
METHODS: Forty-six individuals from two unrelated German kindreds with RMD were examined. Linkage analysis to the RMD locus on chromosome 1q41-q43 was performed.
RESULTS: In kindred A, 15 individuals from four generations, and in kindred B, four individuals from three generations had clinical features of RMD. The most consistent clinical findings were percussion-induced rapid muscle contractions (PIRCs) and muscle mounding, which were present in all 19 affected individuals. Only 12 individuals exhibited muscle rippling, indicating that rippling is not always present in RMD. Twelve of 19 individuals had muscle-related complaints, primarily exertional cramps and stiffness. The mean age at the onset of complaints was 22 years (range, 5 to 54 years). Seven of 19 individuals showed only mechanical-induced muscle irritability but did not have muscular symptoms. Genetic analysis excluded linkage to the RMD locus on chromosome 1q4 in both kindreds.
CONCLUSIONS: The phenotype of RMD is variable but generalized PIRCs are the most obvious and reliable clinical feature of RMD. Diagnostic criteria of RMD should include generalized PIRCs in addition to muscle mounding, rippling, and creatine kinase elevation.
This article has been cited by other articles:
![]() |
W. J. Schulte-Mattler, R. A. Kley, E. Rothenfusser-Korber, S. Bohm, T. Bruning, J. Hackemann, A. Steinbrecher, M. v. During, B. Voss, and M. Vorgerd Immune-mediated rippling muscle disease Neurology, January 25, 2005; 64(2): 364 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Y K Van den Bergh, J M Gerard, J A Elosegi, M U Manto, C Kubisch, and B G H Schoser Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1349 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Woodman, F. Sotgia, F. Galbiati, C. Minetti, and M. P. Lisanti Caveolinopathies: Mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases Neurology, February 24, 2004; 62(4): 538 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schara, M. Vorgerd, N. Popovic, B. G.H. Schoser, K. Ricker, and W. Mortier Rippling Muscle Disease in Childhood J Child Neurol, July 1, 2002; 17(7): 483 - 490. [Abstract] [PDF] |
||||
![]() |
M. Vorgerd, K. Ricker, F. Ziemssen, W. Kress, H. H. Goebel, W. A. Nix, C. Kubisch, B. G.H. Schoser, and W. Mortier A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation Neurology, December 26, 2001; 57(12): 2273 - 2277. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Ansevin, M. Vorgerd, J.-P. Malin, W. Mortier, and C. Kubisch Phenotypic variability in rippling muscle disease Neurology, January 11, 2000; 54(1): 273 - 273. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |